1-4 of 4
Yuichi Hashimoto
Close
Sort by
Journal Articles

TM-233 Exerts Anti-Myeloma Activity and Overcomes Bortezomib-Resistance In Human Multiple Myeloma Cells By Targeting NF-κB and JAK/STAT Dual-Signaling Pathways

Morihiko Sagawa, MD, PhD, Tatsuki Tomikawa, MD, Tomoe Anan, MD, Takayuki Tabayashi, MD, PhD, Reiko Watanabe, MD, PhD, Michihide Tokuhira, MD, PhD, Masaki Ri, MD, PhD, Yuichi Hashimoto, PhD, Shinsuke Iida, MD, PhD, Masahiro Kizaki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4427.
https://doi.org/10.1182/blood.V122.21.4427.4427
Published: 2013
Journal Articles

TM-233, a Novel Analog of 1'-Acetoxychavicol Acetate (ACA), Induces Cell Death in Human Myeloma Cells by Inhibiting Both JAK/STAT and NF-κB Pathways: A Possible New Agent for Overcoming Bortezomib-Resistance.

Morihiko Sagawa, MD, PhD, Tatsuki Tomikawa, MD, Tomoe Nemoto, MD, Takayuki Tabayashi, MD, PhD, Reiko Watanabe, MD, PhD, Michihide Tokuhira, MD, PhD, Masaki Ri, MD, PhD, Yuichi Hashimoto, PhD, Shinsuke Iida, MD, PhD, Masahiro Kizaki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2939.
https://doi.org/10.1182/blood.V120.21.2939.2939
Published: 2012
Journal Articles

5HPP-33, a Novel Tubulin-Polymerization Inhibitor Derived from Thalidomide, Directly Inhibits Proliferation and Induces Apoptosis of Human Multiple Myeloma Cells.

Toyotaka Iguchi, MD, Sawako Oda-Nakazato, MD, Tomomi Noguchi, MS, Yuichi Hashimoto, PhD, Yutaka Hattori, MD, Taketo Yamada, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD
Journal: Blood
Blood (2005) 106 (11): 1586.
https://doi.org/10.1182/blood.V106.11.1586.1586
Published: 2005
Journal Articles

Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis

Hiroshi Sakamoto, Tetsuo Mashima, Atsuo Kizaki, Shingo Dan, Yuichi Hashimoto, Mikihiko Naito, Takashi Tsuruo
Journal: Blood
Blood (2000) 95 (10): 3214–3218.
https://doi.org/10.1182/blood.V95.10.3214
Published: 2000